Bildkälla: Stockfoto

Lipum: Approval To Initiate Phase I Trial - Redeye

Redeye leaves a short comment on Lipum’s announcement of a CTA approval for the phase I trial with SOL-116.

Redeye leaves a short comment on Lipum’s announcement of a CTA approval for the phase I trial with SOL-116.
Börsvärldens nyhetsbrev
ANNONSER